These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4014021)

  • 1. Cardiovascular and pharmacokinetic consequences of combined administration of verapamil and propranolol in dogs.
    Hamann SR; Kaltenborn KE; Vore M; Tan TG; McAllister RG
    Am J Cardiol; 1985 Jul; 56(1):147-56. PubMed ID: 4014021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine-propranolol interaction: dependence of cardiovascular effects on plasma drug concentrations.
    Hamann SR; Kaltenborn KE; McAllister RG
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):182-9. PubMed ID: 2441169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of beta-adrenergic blockade on the cardiovascular response to diltiazem or verapamil in dogs.
    Sullivan KB; Kapur PA
    Anesth Analg; 1986 Nov; 65(11):1099-106. PubMed ID: 3021022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and pharmacokinetic aspects of the interactions between verapamil and pindolol.
    Hamann SR; Kaltenborn KE; McAllister RG
    Pharmacology; 1987; 34(6):326-36. PubMed ID: 3659118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiodepressant actions of combined diltiazem and propranolol in dogs.
    Hamann SR; McAllister RG
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):31-6. PubMed ID: 7511732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.
    Jolly SR; Kipnis JN; Lucchesi BR
    Pharmacology; 1987; 35(5):249-55. PubMed ID: 3423100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic comparison of verapamil and nifedipine in anesthetized dogs.
    Hamann SR; Kaltenborn KE; McAllister RG
    J Cardiovasc Pharmacol; 1985; 7(2):224-31. PubMed ID: 2581072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac conduction interactions of propranolol and verapamil with halothane in pentobarbitone-anaesthetized dogs.
    Hart AP; Royster RL; Johnston WE
    Br J Anaesth; 1988 Dec; 61(6):748-53. PubMed ID: 3207546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of combined administration of verapamil and disopyramide in dogs.
    Lee JT; Davy JM; Kates RE
    J Cardiovasc Pharmacol; 1985; 7(3):501-7. PubMed ID: 2410681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular and adrenergic actions of verapamil or diltiazem in combination with propranolol during halothane anesthesia in the dog.
    Kapur PA; Matarazzo DA; Fung DM; Sullivan KB
    Anesthesiology; 1987 Feb; 66(2):122-9. PubMed ID: 3813074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.
    Hamann SR; Blouin RA; Chang SL; Kaltenborn KE; Tan TG; McAllister RG
    J Pharmacol Exp Ther; 1984 Nov; 231(2):301-5. PubMed ID: 6491984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of verapamil in the beta-blocked dog.
    Iberti TJ; Weiner B; Stein JS; Premus G; Benjamin E
    Crit Care Med; 1985 Feb; 13(2):105-8. PubMed ID: 3967499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.
    McCourty JC; Silas JH; Tucker GT; Lennard MS
    Br J Clin Pharmacol; 1988 Mar; 25(3):349-57. PubMed ID: 3358897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of verapamil.
    Hamann SR; Blouin RA; McAllister RG
    Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dantrolene and verapamil on atrioventricular conduction and cardiovascular performance in dogs.
    Lynch C; Durbin CG; Fisher NA; Veselis RA; Althaus JS
    Anesth Analg; 1986 Mar; 65(3):252-8. PubMed ID: 3954091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amrinone and verapamil-propranolol induced cardiac depression during isoflurane anesthesia in dogs.
    Makela VH; Kapur PA
    Anesthesiology; 1987 Jun; 66(6):792-7. PubMed ID: 3592277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupivacaine accentuates the cardiovascular depressant effects of verapamil in conscious dogs.
    Edouard A; Froidevaux R; Berdeaux A; Ahmad R; Samii K; Noviant Y
    Eur J Anaesthesiol; 1987 Jul; 4(4):249-59. PubMed ID: 3653084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil on electrophysiologic properties of blood superfused cardiac Purkinje fibers.
    Danilo P; Hordof AJ; Reder RF; Rosen MR
    J Pharmacol Exp Ther; 1980 May; 213(2):222-7. PubMed ID: 7365685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.